Oct 2026· Frontiers in Oncology· Vol 16· 0 citations· 36 references
Medicine
TL;DR
Insomnia symptoms were highest at baseline but improved for the low probability and moderate probability groups but improved for the low probability and moderate probability groups over 3 years post-recruitment.
Abstract
Background Sleep disruptions are common in cancer survivors and can negatively impact quality of life. Young breast cancer survivors face unique challenges and may have distinct sleep patterns. We examined trajectories of insomnia symptoms over 3 years among young survivors. Methods 836 women, ≤45 years old with stage I-III breast cancer, were recruited to the Menstrual Cycle Maintenance and Quality of Life After Breast Cancer Study within 8 months of diagnosis. Insomnia symptoms were assessed at 6-month intervals from baseline through 3 years post-recruitment, using the Women’s Health Initiative Insomnia Rating Scale (WHIIRS). Group-based trajectory modeling was used to identify distinct trajectories of insomnia symptoms. The final model was chosen by comparing the average posterior probability of assignment (PPA) and examining the distinctiveness and interpretability of the trajectories. Key demographic, quality of life and clinical variables were assessed in multinomial logistic regression models as potential factors associated with group membership. Results The mean age of participants was 38 years (range: 20–45 years) at enrollment. Three distinct insomnia trajectories were identified: low probability of insomnia (n=277, 33.1%), moderate probability (n=354, 42.4%), and high probability (n=205, 24.5%). Average PPA was between 75%-82% for each group. Insomnia symptoms were highest at baseline but improved for the low probability and moderate probability groups. In adjusted models, older age (p=0.02), lower education (p=0.03), having received chemotherapy (p=0.03), night sweats (p=0.02), lower SF-12 physical component scores (poorer physical functioning, p<0.0001), and lower SF-12 mental health component scores (p<0.0001) were associated with participants in the moderate and high probability insomnia groups compared to those in the low probability group. Conclusion Insomnia symptoms are problematic for many young breast cancer survivors. Future studies are needed to determine whether early identification and intervention can modify these insomnia symptom trajectories and improve broader survivorship outcomes.
The longitudinal course (trajectory) of symptoms in patients with cancer has been understudied. Sleep disturbance, pain, physical function impairment, anxiety, depression, and energy deficit/fatigue (SPPADE) are particularly common in patients with cancer. This study characterizes the trajectory patterns of SPPADE symp...
Kurt Kroenke, V. Grzegorczyk, Min-Ji K. Lee et al.· Supportive Care in Cancer· 0 citations
BACKGROUND
Insomnia is a frequent and distressing concern for cancer survivors and is often associated with increased risk for depression and anxiety. Although cognitive behavioral therapy for insomnia (CBT-I) has been established as an effective treatment, brief, virtually delivered CBT-I with content targeted to surv...
Emma G. Balkind, K. A. Arditte Hall, Christopher M. McGrory et al.· Journal of psychosocial onco...· 0 citations
To characterize depressive symptom trajectories among ethnically diverse survivors of young adult cancer during the first year following a de novo cancer diagnosis and identify sociodemographic and clinical factors associated with longitudinal depressive symptom severity.
Young adults aged 18-39 years were...
M. B. Echeverria, J. Stal, Dayanara Ruiz et al.· Cancer Epidemiology, Biomark...· 0 citations
BACKGROUND
Pain at specific anatomical sites and depressive symptoms commonly co-occur in middle-aged and older adults, but their longitudinal association and the potential role of sleep duration remain unclear. This study examined whether site-specific pain was associated with depressive symptom trajectory membership...
Mei-Han Liu, You-Qiang Li· Journal of Affective Disorde...· 0 citations
Although most patients with head and neck cancer experienced mild-to-moderate symptoms, a clinically important subgroup remained at elevated risk for persistent symptoms, a clinically important subgroup remained at elevated risk for persistent symptoms.
Alyssa L. Fenech, Elyse R. Park, L. Wirth et al.· Journal of cancer survivorsh...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.